Measurements and Standards for Advancing the Development of Tissue-Engineered Medical Products: The regenerative medicine industry has identified a lack of reliable methods for characterizing products as “possibly the single greatest challenge for the field”. Several attempts to legislate efforts to develop regenerative medicine standards have been proposed as bills in the U.S. congress. Product quality attributes should be well-defined and validated measurement processes are required to establish that manufactured products possess these attributes. This session will examine how products may be characterized for release and the measurements and standards that can support these efforts. In addition, needs for improved measurements and new standards may be emphasized. The speakers will focus on efforts to bring products to market, how the products are characterized, the key measurements for their release and how documentary standards may assist in this process. Relevant stakeholders from different sectors will be recruited as speakers: standards organizations, universities, government and industry. Speakers will place particular focus on needs in the current measurement and standards infrastructure and will highlight opportunities for future research efforts.